Sitafloxacin
- Level
- Commodity
- Parent
- 51282900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282937This classification denotes a quinolone antibiotic with the molecular formula C19H18ClF2N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3GJC60U4Q8, chemically known as 7-((7s)-amino-5-azaspiro(2,4)heptan-5-yl)-8-chloro-6-fluoro-1-((1r,2r)-cis-2-fluoro-1-cyclopropyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid but generally known as sitafloxacin, which bears US NIH Compound Identifier 73011. European Medicines Agency schedules Sitafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10539MIG. The term SITAFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). World Health Organization schedules sitafloxacin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule sitafloxacin under HS 29334910 and SITC 51575. As of Q4 2014, SITAFLOXACIN remains the US FDA Preferred Term for this commodity. Sitafloxacin bears US NLM identifiers UMLS ID C0171447 and NCI Concept Code C76922. SMILES: CLC1C(N2CC3(CC3)C(N)C2)C(F)CC2C1N(C1C(F)C1)CC(C2=O)C(=O)O.
Same parent
Under 51282900 · 57Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.